ARYA Sciences Acquisition Corp V
Status: Liquidated
U=S
IPO Proceeds, $M | $149.50M |
---|---|
IPO Date | Jul 13, 2021 |
CEO | Adam Stone |
Left Lead | Jefferies |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
North American or European companies in the life sciences and medical technology sectors |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Closing Date | Jul 17, 2023 |
ARYE
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on ARYA Sciences Acquisition Corp V:
- Structure and cap table
- 8 directors & officers
- 6 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Joseph Edelman | 65 | Chairman |
Adam Stone | 41 | Chief Executive Officer and Director |
Michael Altman | 39 | Chief Financial Officer and Director |
Konstantin Poukalov | 37 | Chief Business Officer |
Todd Wider | 56 | Director |
Jake Bauer | 42 | Director |
Sanjiv K. Patel | 48 | Director |
Debra Yu | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Jefferies | Joint BR | 6,500,000 | units |
Goldman Sachs | Joint BR | 6,500,000 | |
13,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 6 filings.